Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

被引:24
作者
Takei, Hiroaki [1 ,2 ,4 ]
Shinoda, Jun [1 ,2 ,3 ]
Ikuta, Soko [5 ]
Maruyama, Takashi [5 ]
Muragaki, Yoshihiro [5 ]
Kawasaki, Tomohiro [1 ,2 ,4 ]
Ikegame, Yuka [1 ,2 ,3 ]
Okada, Makoto [1 ,2 ]
Ito, Takeshi [1 ,2 ]
Asano, Yoshitaka [1 ,2 ,3 ]
Yokoyama, Kazutoshi [1 ,2 ]
Nakayama, Noriyuki [4 ]
Yano, Hirohito [4 ]
Iwama, Toru [4 ]
机构
[1] Kizawa Mem Hosp, Dept Neurosurg, Minokamo, Gifu, Japan
[2] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan
[4] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan
[5] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan
基金
日本学术振兴会;
关键词
C-11-methionine; C-11-choline; F-18-fluorodeoxyglucose; positron emission tomography; glioma; isocitrate dehydrogenase mutation; oncology; C-11-METHIONINE PET; C-11; METHIONINE; IDH2; MUTATIONS; BRAIN-TUMORS; F-18-FDG PET; SURVIVAL; C-11-CHOLINE; DIAGNOSIS; NECROSIS; CHOLINE;
D O I
10.3171/2019.5.JNS19780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
收藏
页码:1010 / 1019
页数:10
相关论文
共 50 条
  • [31] A practical approach to the optimization of positron emission tomography imaging agents for the central nervous system
    Auberson, Yves P.
    Lievre, Akane
    Desrayaud, Sandrine
    Briard, Emmanuelle
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2022, 65 (13) : 343 - 350
  • [32] The WHO classification of tumors of the central nervous system 2021 Changes in the diagnostics of diffuse gliomas and implications for clinical practice
    Weller, Michael
    Knobbe-Thomsen, Christiane B.
    Le Rhun, Emilie
    Reifenberger, Guido
    [J]. ONKOLOGE, 2022, 28 (02): : 155 - 163
  • [33] Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors
    Kim, Byung Sup
    Kim, Yuil
    Kong, Doo-Sik
    Nam, Do-Hyun
    Lee, Jung-Il
    Suh, Yeon-Lim
    Seol, Ho Jun
    [J]. JOURNAL OF NEUROSURGERY, 2018, 129 (06) : 1384 - 1396
  • [34] Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining 18F-fluorodeoxyglucose Positron Emission Tomography with Arterial Spin Labeling
    Hatakeyama, Junya
    Ono, Takahiro
    Takahashi, Masataka
    Oda, Masaya
    Shimizu, Hiroaki
    [J]. NEUROLOGIA MEDICO-CHIRURGICA, 2021, 61 (06) : 367 - 375
  • [35] 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival
    Seki, Norio
    Sakamoto, Setsu
    Karube, Yoko
    Oyaizu, Takeshi
    Ishihama, Hiromi
    Chida, Masayuki
    [J]. ANNALS OF NUCLEAR MEDICINE, 2014, 28 (03) : 257 - 262
  • [36] 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival
    Norio Seki
    Setsu Sakamoto
    Yoko Karube
    Takeshi Oyaizu
    Hiromi Ishihama
    Masayuki Chida
    [J]. Annals of Nuclear Medicine, 2014, 28 : 257 - 262
  • [37] Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma
    Back, M.
    Rodriguez, M.
    Jayamanne, D.
    Khasraw, M.
    Lee, A.
    Wheeler, H.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (09) : 556 - 562
  • [38] Processing vestibular impulses in the central nervous system.: Study using positron emission tomography
    Kisely, M
    Tóth, A
    Emri, M
    Lengyel, Z
    Kálvin, B
    Horváth, G
    Trón, L
    Bogner, B
    Sziklai, I
    [J]. HNO, 2001, 49 (05) : 347 - +
  • [39] Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system
    Ruiqing Ni
    Linjing Mu
    Simon Ametamey
    [J]. Acta Pharmacologica Sinica, 2019, 40 : 351 - 357
  • [40] Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system
    Ni, Ruiqing
    Mu, Linjing
    Ametamey, Simon
    [J]. ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) : 351 - 357